๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Obesity or Overweight

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea NCT07571109Phase 392 sites๐Ÿ“ Gilbert๐Ÿ“ Bradenton๐Ÿ“ Naples Novo Nordisk A/S ยท Tests: NNC0487-0111, Placebo (matched to NNC0487-0111) Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity NCT07136714Phase 41 site๐Ÿ“ Hillerรธd Nordsjaellands Hospital ยท Tests: Semaglutide Injectable Product, Placebo A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight NCT07710768Phase 11 site๐Ÿ“ Cypress Novo Nordisk A/S ยท Tests: UBT251, Cocktail (Warfarin/Caffeine/Midazolam) A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight NCT07842640Phase 11 site๐Ÿ“ Baltimore Ascletis Pharma (China) Co., Limited ยท Tests: ASC35 Injection B, for subcutaneous use, ASC35 Placebo Injection B, for subcutaneous use, Tirzepatide Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss NCT07292441Phase 32 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Gan & Lee Pharmaceuticals. ยท Tests: GZR18 injection, Placebo Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities NCT07752979Phase 264 sites๐Ÿ“ Pelham๐Ÿ“ Scottsdale๐Ÿ“ Tucson AbbVie ยท Tests: ABBV-295, Placebo Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity) NCT05770570Phase 21 site๐Ÿ“ New York Memorial Sloan Kettering Cancer Center ยท Tests: Counseling, Text Messages, Phone calls, Self-monitoring tools The 6-minute Pegboard and Ring Test in Overweight and Obese Individuals NCT06742112n/a1 site๐Ÿ“ KฤฑrลŸehir Kirsehir Ahi Evran Universitesi Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain NCT07708064NA1 site๐Ÿ“ Springfield ORI Community and Evaluation Services ยท Tests: JITAI Combined with psychological intervention, Active Control A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant NCT07710729Phase 11 site๐Ÿ“ Montreal Novo Nordisk A/S ยท Tests: UBT251, Oral contraceptive, Acetaminophen Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes NCT07685808Phase 221 sites๐Ÿ“ Mobile๐Ÿ“ Walnut Creek๐Ÿ“ Waterbury Regeneron Pharmaceuticals ยท Tests: Olatorepatide, Placebo A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity NCT06842186Phase 1, Phase 27 sites๐Ÿ“ Phoenix๐Ÿ“ Baltimore๐Ÿ“ Chisinau Wave Life Sciences USA, Inc. ยท Tests: WVE-007 A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity NCT07843498Phase 33 sites๐Ÿ“ Anniston๐Ÿ“ Port Orange๐Ÿ“ Nashville Hoffmann-La Roche ยท Tests: Petrelintide, Placebo FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing) NCT06724406NA1 site๐Ÿ“ Chapel Hill University of North Carolina, Chapel Hill ยท Tests: Family Skills Training Session Quantity: 5, Family Skills Training Session Mode: In-person, Family Skills Training Contโ€ฆ A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity NCT07395687Phase 23 sites๐Ÿ“ Cypress๐Ÿ“ Overland Park๐Ÿ“ Montreal Novo Nordisk A/S ยท Tests: UBT251, Placebo Effect of Strength-resistance Exercise in the Reduction of Gestational Diabetes in Pregnant Women with Overweight or Obesity NCT05840497NA1 site๐Ÿ“ Pamplona Fundacion Miguel Servet ยท Tests: Resistance exercise A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight NCT07738614Phase 12 sites๐Ÿ“ San Antonio๐Ÿ“ Singapore Eli Lilly and Company ยท Tests: Eloralintide, Placebo, Acetaminophen A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar NCT07284511Phase 2, Phase 34 sites๐Ÿ“ Montreal๐Ÿ“ Montreal๐Ÿ“ Montreal McGill University Health Centre/Research Institute of the Mโ€ฆ ยท Tests: Tirzepatide, Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM), Carbohydrate Counting, No Meal Aโ€ฆ Family-Based Nutrition Intervention to Prevent Overweight and Obesity in School-Age Children. NCT07159971NA1 site๐Ÿ“ Mรฉxico Claudia Teresa Tovar Palacio ยท Tests: School B, Control Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight NCT07467447Phase 21 site๐Ÿ“ Shenzhen Hudson Biotech ยท Tests: Retatrutide (LY3437943), Placebo, Standardized diet and physical activity counseling throughout the study. Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes NCT07835360n/a2 sites๐Ÿ“ Mexico City๐Ÿ“ Mexico City Instituto Nacional de Ciencias Medicas y Nutricion Salvadorโ€ฆ Uterine Preservation Via Lifestyle Transformation NCT05903131Phase 23 sites๐Ÿ“ St Louis๐Ÿ“ Albuquerque๐Ÿ“ Oklahoma City Washington University School of Medicine ยท Tests: Telemedicine behavioral weight intervention, Progestin, Enhanced usual care, Levonorgestrel-releasing IUD. A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity NCT07437079Phase 11 site๐Ÿ“ Lenexa Novo Nordisk A/S ยท Tests: NNC6989-0001, Placebo (NNC6989-0001) The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass NCT05320796Phase 41 site๐Ÿ“ Schlieren Prof Urs Zingg ยท Tests: upper endoscopy Tirzepatide Weight Loss for MRD+ Early Breast Cancer NCT06517212Phase 21 site๐Ÿ“ Dallas Baylor Research Institute ยท Tests: Tirzepatide High-Intensity Interval Training in Low Versus Normal Oxygen: Effects on Body Fat and Gut Health in Adults Aged 50-75 With Overweight or Obesity (HYPOXFAT) NCT07796971NA1 site๐Ÿ“ Bellerive-sur-Allier Laboratoire des Adaptations Mรฉtaboliques ร  l'Exercice en coโ€ฆ ยท Tests: Hypoxic High-Intensity Interval Training, Normoxic High-Intensity Interval Training A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes NCT07670416Phase 321 sites๐Ÿ“ Zhengzhou๐Ÿ“ Xianyang๐Ÿ“ Ningbo Hoffmann-La Roche ยท Tests: Enicepatide, Placebo Acute Effects of Isoenergetic HIIE vs. MICE on Key Parameters of Fat Mass Loss in Young Females With Overweight or Obesity NCT06868862NA1 site๐Ÿ“ Sรฃo Paulo Laboratoire des Adaptations Mรฉtaboliques ร  l'Exercice en coโ€ฆ ยท Tests: Exercise Addressing the Double Burden of Malnutrition in Guatemala NCT06750120NA1 site๐Ÿ“ Tecpรกn Guatemala Brigham and Women's Hospital ยท Tests: Family food ration, Optimal weight counseling, Enhanced Usual Care A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes NCT07658560Phase 21 site๐Ÿ“ Beijing BrightGene Bio-Medical Technology Co., Ltd. ยท Tests: BGM0504 tablets, BGM0504 tablets, BGM0504 tablets, BGM0504 tablets, BGM0504 placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy